Business
Evogene Schedules First Quarter 2025 Financial Results Release
May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Wednesday, May 21, 2025.
About this update from Evogene Ltd.
[{"type":"text","content":"Zoom conference call scheduled for May 21, 2025, 9:00 AM ET","length":59,"tagName":"p"},{"type":"text","content":"REHOVOT, Israel, May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Wednesday, May 21, 2025.","length":333,"tagName":"p"},{"type":"image","alt":"Evogene Logo","displaySize":"","headline":null,"caption":"Evogene Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":230,"url":"https://media.zenfs.com/en/prnewswire.com/1a77353fc37db2ed5b8a4b3f7afbffbc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1EbKT9twNzyPVwlm3gHt9w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/1a77353fc37db2ed5b8a4b3f7afbffbc","width":400,"height":230}}},{"type":"text","content":"Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).","length":132,"tagName":"p"},{"type":"text","content":"To join the conference, please register in advance:","length":51,"tagName":"p"},{"type":"text","content":"https://www.veidan-conferenceing.com/evogene","length":44,"tagName":"p"},{"type":"text","content":"The entire conference will be available online on the company's website a few days after.","length":93,"tagName":"p"},{"type":"text","content":"About Evogene:","length":14,"tagName":"p"},{"type":"text","content":"Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.","length":314,"tagName":"p"},{"type":"text","content":"Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).","length":326,"tagName":"p"},{"type":"text","content":"Evogene ...